The largest database of trusted experimental protocols

Cd11b pe m1 70

Manufactured by BD
Sourced in United States

CD11b-PE (M1/70) is a fluorescent-conjugated antibody that specifically binds to the CD11b antigen, also known as the integrin alpha M chain or Mac-1 alpha chain. CD11b is expressed on the surface of myeloid cells, including monocytes, macrophages, and granulocytes. This antibody can be used for the identification and analysis of these cell types in flow cytometry applications.

Automatically generated - may contain errors

3 protocols using cd11b pe m1 70

1

Neutrophil Recruitment Analysis in Alum-Induced Mouse Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6J mice aged 6–8 weeks were intraperitoneally injected with 700 mg of alum and evaluated 12 h later. The peritoneal cavity was washed with 5 ml of PBS. Peritoneal exudate cells (PECs) were analyzed by flow cytometry. The recruitment of neutrophils was visualized with CD11b-PE (M1/70; BD Biosciences) and Ly-6G-APC (1A8; eBioscience). PI (Sigma) was used to exclude dead cells. Neutrophil (CD11b+Ly6G+) recruitment was analyzed on a CytoFLEX (Beckman Coulter) (45 (link)).
+ Open protocol
+ Expand
2

Immune Cell Profiling in Tumor Microenvironment

Check if the same lab product or an alternative is used in the 5 most similar protocols
4T1 tumours were excised from CSG and TNFα‐CSG‐treated mice, minced and incubated in DMEM high‐glucose medium containing 0.1 mg/ml DNase I (Sigma) and 0.5 mg/ml collagenase IV (Sigma) for 1 h at 37°C under gentle rotation. The cell suspension was passed through a 70‐μm membrane and subsequently washed with FACS buffer [1% BSA (w/v, Sigma) in PBS]. For analysis of immune cells, viable cells (Zombie Aqua™ selection; BioLegend) were stained with the following antibodies: CD45‐APC‐efluor 780 (30‐F11; eBioscience, 1:200), CD3‐BUV395 (145‐2C11; BD, 1:200), CD4‐BV510 (Gk1.5; BD, 1:100), CD8‐PE‐CF594 (53‐6.7; BD, 1:300), CD11b‐PE (M1/70; BD, 1:300), F4/80‐AF647 (BM8; BioLegend, 1:300) and Ly6G‐FITC (1A8; BD, 1:100). For analysis of cytotoxic and regulatory T cells, viable cells were stained with the following antibodies: CD3‐APC‐eFluor 780 (145‐2C11; eBioscience, 1:200), CD4‐FITC (Gk1.5; eBioscience, 1:200), CD8‐PerCp‐eFluor 710 (53‐6.7; eBioscience, 1:200), CD25PE‐efluor 610 (PC61.5; eBioscience, 1:100), FoxP3‐AF647 (150; BioLegend, 1:100) and granzyme B (GB11; BD, 1:100). For intracellular staining (granzyme B and FoxP3), cells were permeabilised with True‐Nuclear™ Transcription Factor Buffer (Biolegend). Cells were sorted on a BD SORP Fortessa and analysed on BD FACSDiva software version 8.0.1 (BD Biosciences, USA).
+ Open protocol
+ Expand
3

Neutrophil Depletion and Flow Cytometric Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophil granulocytes were depleted by i.p. injection of 500 μg anti-Ly6G-antibody, clone 1A8 (BioXCell, #BE0075-1) and corresponding isotype control (InVivoMab Rat IgG2a, clone 2A3, BioXCell, #BE0089) 16 h prior to osmotic mini pump implantation.
For flow cytometric analysis of circulating neutrophils EDTA anticoagulated blood was collected 48 h after implantation of osmotic mini pumps and stained followed by lysis of red blood cells. Cells were fixed in 1% neutral buffered paraformaldehyde for 20 min at room temperature, according to a protocol by [6 (link)]. To prevent unspecific binding, cells were incubated with anti-CD16/32 antibody (clone 93; Biolegend, San Diego, CA, USA) before antibody staining.
CD11b-PE (M1/70, BD Biosciences, San Jose, CA, USA) and anti-Ly-6C-AlexaFluor® 488 (HK1.4) were used to detect neutrophils and monocytes [21 (link)]. Respective isotype control IgGs were used to set all flow cytometric gates. Measurement and data analysis were performed using a Gallios™ Flow Cytometer, and Kaluza® Flow Analysis Software (both Beckman Coulter Inc., Krefeld, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!